In response to the growing impact of the COVID-19 Coronavirus in Europe, a number of countries have implemented national controls to restrict the export of medicines and medical equipment, such as face masks, gloves, and protective clothing.

Over the weekend, the EU Commission reviewed actions taken by Member States and, while it has discouraged Member States from adopting measures which would limit intra-EU trade, it has introduced a temporary export ban on exports of certain medical/protective equipment to destinations outside the EU.

EU wide controls under Commission Implementing Regulation (EU) 2020/402

On Sunday 15 March 2020 the Commission published an Implementing Regulation that prohibits the export of the personal protective equipment listed in Annex I to the Implementing Regulation, whether or not originating in the EU, to destinations outside the EU, unless a licence is first obtained from a Member State.  The Implementing Regulation was made pursuant to Article 5 of Regulation (EU) 2015/479, which permits the Commission to adopt temporary export control measures in order to prevent or remedy critical situations arising from shortages of essential products.

Annex I to the new Regulation covers a range of items (including mouth-nose-protection equipment, gloves, and other protective garments) for the protection of the wearer against potentially infectious material and for the protection of the environment against potentially infectious material spread by the wearer, as well as covering protective spectacles and visors, and face shields. For full categories and descriptions, and corresponding customs codes that correspond to or which can include these items, please see the table in Annex I.

Export authorisations will be required for the export outside the Union of listed personal protective equipment, whether or not it originates in the Union. As a result, such goods transiting through the EU could also be subject to the authorisation obligation.

An application for an export authorisation can be made to Member States using the form set out in Annex II to the Implementing Regulation.

The Regulation entered into force immediately on publication yesterday (15 March 2020), and will apply for a period of 6 weeks.  Within 12 working days of the measure entering into force, the Commission must decide whether to adopt longer-lasting restrictions (which could include quantitative restrictions on exports, as well as licensing requirements).

The Commission is also expected to publish guidance on the restrictions on exports of protective equipment during the course of today.

EU dual-use export controls

The EU’s existing dual-use export control regime will also continue to apply to any items that are listed in the EU dual use list (Annex I to Regulation 428/2009, as amended). These are specifically intended to capture more sophisticated items with both a civil application and a military or WMD application (consumer or civil grade equipment is less likely to be covered by these controls).

In particular, 1A004 covers, inter alia, full face masks (i.e. gas masks including powered air purifying respirators), filter canisters and decontamination equipment (and specially designed components) therefor, designed or modified for defence against… “biological agents”; and protective suits, gloves and shoes, specially designed or modified for defence against… “biological agents”. For these purposes, “biological agents” means pathogens or toxins, selected or modified (such as altering purity, shelf life, virulence, dissemination characteristics, or resistance to UV radiation) to produce casualties in humans or animals, degrade equipment or damage crops or the environment. Further advanced protective equipment for biological manufacture and handling is also listed under 2B352.

National controls in EU Member States

In addition, a number of Member States have also introduced national export bans of medical equipment:

  • The Czech Republic has adopted measures under which manufacturers, distributors and importers of personal protective equipment, are prohibited from selling certain personal protective equipment (chiefly class FFP3 respiratory protection masks and medical veils) other than to the state of the Czech Republic and its organisational units or to distributors of personal protective equipment that are incorporated or established in the territory of the Czech Republic (and which in turn may resell or transfer personal protective equipment only to the state or other state suppliers). The restrictions continue to evolve rapidly, and an initial exception allowing for sales to hospitals and healthcare and social care providers has been removed in the most recent restrictions.
  • In France, the Government has requisitioned stocks of FFP2 respiratory protection masks held by any public and private legal entities, as well as stocks of anti-projection masks (surgical masks) held by distributors or manufacturers of these products (under Decree No. 2020-190, dated 3 March 2020). FFP2 type masks, as well as respiratory masks, produced between the publication of the decree (4 March 2020) and 31 May 2020 have also requisitioned.
  • In Germany, as of 19 March 2020 there are no additional national measures in force in response to the Coronavirus crisis. Earlier in the month, export restrictions for medical equipment were temporarily adopted. A general decree was issued on 4 March 2020, and further updated on 12 March 2020, that prohibited the export and intra-EU transfer of specific types of medicinal protective gear (transits of the goods listed through Germany continued to be allowed), although certain exemptions and authorizations were available. These restrictions were repealed on 19 March 2020, although the German government noted that such restrictions may be reintroduced if necessary. Restrictions for exports out of the EU for medical equipment, based on the Implementing Regulation and as set out above, continue to apply.
  • Poland adopted measures on 5 March, limiting export and intra-community transfer from the territory of Poland of medicinal products and medical equipment that may become unavailable on the Polish market.  These include (amongst others) medicinal products used against flu, as well as other medical equipment, including masks, injection needles, medical caps, surgical gowns, and other surgical garments.  Export of these products is allowed only subject to the consent of the Main Pharmaceutical Inspector.

Russian export ban and export controls

Russia has introduced a temporary ban on the exportation of 17 types of medical equipment, including face masks, plastic shoe covers, gloves, surgical scrubs, gas masks, protective suits, etc., under Governmental Decree No. 223 dated 2 March 2020. The ban shall remain effective from 2 March 2020 until 1 June 2020. The ban will apply both to goods which were placed under the customs procedures prior to entering into force of Decree No. 223 and to goods whose actual export from the customs territory of Russia is carried out after the entry into force of Decree No. 223. The ban does not apply to the export of listed goods: (i) for rendering international support to the foreign states based on the decisions of the Russian Government or (ii) by the individuals for personal use.

Under the Russian export control legislation certain complicated medical equipment may also be subject to export restrictions set out under Federal law No. 183-FZ “On export control” dated 18 July 1999. For example, export of full-face protective masks, isolated laboratories, certain biological protective boxes will be subject to the license authorisation of the Federal Service for Technical and Export Control of Russia.

We will continue to monitor bans and export controls on medicines and medical supplies as governments react to the pandemic, and will provide further updates accordingly.

Author

Sunwinder (Sunny) Mann is a Partner and is Chair of our International Commercial and Trade Global Practice Group. Our Trade team has been ranked Tier 1 by Legal 500 UK for over 20 years. He is currently based in our London office, but has also worked in our offices in Washington, D.C., New York, Sydney and Hong Kong. Sunny's practice focuses on international trade compliance and, in particular, export controls and trade sanctions, as well as anti-bribery. He has worked on a number of significant compliance and investigations matters. He leads our Firm's Geopolitical Risks Taskforce, having coordinated our Firm's support to clients responding to the ongoing Russia crisis.

Author

Tristan Grimmer is a partner in Baker McKenzie's London office and the UK Head of the International Trade Practice Group. He is also a member of the Compliance & Investigations and the International Trade and Competition practice groups. Tristan joined Baker McKenzie as a trainee in March 2004, qualifying in March 2006. He has advised on parallel investigations by authorities in the United States, Switzerland, Brazil and Japan, and has spent time working in Baker McKenzie's Chicago office. Tristan is named as a "Leading Individual" for EU And Competition: Trade, WTO Anti-Dumping and Customs in the UK Legal 500 2023 directory.

Author

Anahita heads Baker McKenzie's International Trade Practice in Germany and is a member of our EMEA Steering Committee for Compliance & Investigations. Anahita is Global Lead Sustainability Partner for our Industrials, Manufacturing and Transportation Industry Group and a member of the ABA International Human Rights Steering Committee. Anahita focuses her practice on global investigations and white-collar crime proceedings before German authorities and courts. She has significant experience advising on internal compliance programs, accompanying internal and external investigations and self-disclosures, inter alia in cases of breaches of sanctions, export control, human rights, data protection and foreign investment review, closely collaborating with the competent authorities.

Author

Author

Alexander advises clients on the international, European and public law governing international trade. His practice encompasses advising on sanctions and embargoes, trade defense instruments, export control regulations, foreign investment review and international investment law as well as human rights and sustainability due diligence and compliance, including on the German Supply Chain Due Diligence Act and the EU Directives on ESG compliance. Alexander furthermore advices on trade policy, free trade agreements, disputes arising out of these and customs matters.

Author

Author

Ross Evans is an Associate in Baker McKenzie's London office.